Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture

Research output: Contribution to journalArticlepeer-review


Acute myeloid leukemias (AMLs) are consistently associated with chromosomal rearrangements that result in the generation of chimeric genes and fusion proteins. One of the two affected genes is frequently a transcription factor involved in the regulation of hematopoietic differentiation. Recent findings suggest a common leukemogenic mechanism for the fused transcription factor: abnormal recruitment of histone deacetylase (HDAC)-containing complexes to its target promoters. Inhibition of HDAC enzymatic activity reverts the leukemic phenotype in vitro and therefore represents a plausible strategy for antileukemic therapy. In this review, we first briefly describe the molecular structure and mechanisms of the most frequent AML-associated fusion proteins (RAR, MLL, and CBF fusions) and then summarize available knowledge about their effects on the nuclear architecture. We propose that alteration of nuclear compartmentalization might represent an additional common mechanism of leukemogenesis.

Original languageEnglish
Pages (from-to)42-53
Number of pages12
JournalSeminars in Hematology
Issue number1
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture'. Together they form a unique fingerprint.

Cite this